bioRxiv Science⌕ Search

Biology subjects

Thorgeirsson, T.

Publications and source records attributed to Thorgeirsson, T..

2 recordsLinked to original sources

Deep learning based brain age prediction uncovers associated sequence variants

Machine learning algorithms trained to recognize age-related structural changes in magnetic resonance images (MRIs) of healthy individuals can be used to predict biological brain age in independent samples. The difference between predicted and chronological age, predicted age difference (PAD), is a phenotype holding promise for the study of normal brain ageing and brain diseases, and genetic discovery via genome-wide association studies (GWASs). Here, we present a new deep learning approach to predict brain age from a T1-weighted MRI. The method was trained on a dataset of healthy Icelanders (N = 1264) and tested on two datasets, the IXI (N = 544) and UK Biobank (N = 12395) datasets, utilizing transfer learning to improve accuracy on new sites. A GWAS of PAD in the UK Biobank data (discovery set: N=12395, replication set: N=4453) yielded two sequence variants, rs1452628-T ({beta}=-0.08, P = 1.15 {middle dot} 10-9) and rs2435204-G ({beta}=0.102, P = 9.73 {middle dot} 10-12). The former is near KCNK2 and correlates with reduced sulcal width, whereas the latter correlates with reduced white matter surface area and tags a well-known inversion at 17q21.31 (H2). The genetic association analysis was also confined to variants known to associate with brain structure, yielding three additional sequence variants associating with PAD.

neuroscience↗

Genome-wide association study implicates CHRNA2 in cannabis use disorder

Introductory paragraphCannabis is the most frequently used illicit psychoactive substance worldwide1. Life time use has been reported among 35-40% of adults in Denmark2 and the United States3. Cannabis use is increasing in the population4-6 and among users around 9% become dependent7. The genetic risk component is high with heritability estimates of 518-70%9. Here we report the first genome-wide significant risk locus for cannabis use disorder (CUD, P=9.31x10-12) that replicates in an independent population (Preplication=3.27x10-3, Pmetaanalysis=9.09x10-12). The finding is based on a genome-wide association study (GWAS) of 2,387 cases and 48,985 controls followed by replication in 5,501 cases and 301,041 controls. The index SNP (rs56372821) is a strong eQTL for CHRNA2 and analyses of the genetic regulated gene expressions identified significant association of CHRNA2 expression in cerebellum with CUD. This indicates a potential therapeutic use in CUD of compounds with agonistic effect on the neuronal acetylcholine receptor alpha-2 subunit encoded by CHRNA2. At the polygenic level analyses revealed a significant decrease in the risk of CUD with increased load of variants associated with cognitive performance.

genomics↗